Can "Ultra-low" dose Rituximab work for RA? At day 3 of #ACR21, the REDO trial presented data in abs1443 in an oral presentation challenging how low we can go with rituximab for rheumatoid arthritis. Dr. Eric Dein ( @ejdein1) shares highlights. https://t.co/jaTjBPRKVe https://t.co/7Q9nxlUt7R